Formulations of 14-epi-analogues of vitamin D

An oral formulation wherein said formulation is a dry formulation which comprises:

• at least one 14-epi-analogue of vitamin D in a concentration of between 0.001 and 50% (weight),
• carboxymethylcellulose in a concentration between 0.1% and 50% (weight), and
• one or more optional pharmaceutically acceptable excipient(s)
• wherein said 14-epi-analogue of vitamin D is inecalcitol and wherein the formulation is characterized by an improved absorption profile over the medium chain triglycerides formulation of said 14-epi-analogue of vitamin D.